Contents
pdf Download PDF
pdf Download XML
344 Views
3 Downloads
Share this article
Research Article | Volume: 29 Issue 1 (Jan-Dec, 2024) | Pages 1 - 2
Bioresorbable Vascular Scaffolds: Next-Generation Solutions in Coronary Artery Disease
 ,
 ,
1
Department of Cardiology, Harvard Medical School, USA
2
Division of Cardiovascular Medicine, Imperial College London, UK
3
Cardiovascular Research Institute, University of Sydney, Australia
Under a Creative Commons license
Open Access
Published
Sept. 19, 2024
Abstract

Bioresorbable vascular scaffolds (BVS) represent a promising advancement in the treatment of coronary artery disease (CAD), providing temporary mechanical support to the vessel during healing and gradually dissolving thereafter. This technology aims to overcome some limitations of traditional drug-eluting stents (DES), including permanent foreign-body implantation and late-stent thrombosis. This article reviews the design principles, clinical outcomes, challenges, and future prospects of BVS in CAD treatment.

Keywords
Recommended Articles
Research Article
Study of Thyroid Dysfunction among Hiv Infected Patients on Highly Active Anti-Retroviral Therapy (Haart): A Cross-Sectional Study
Published: 30/01/2025
Could endothelial dysfunction be a surrogate end point for coronary artery disease
...
Can If inhibition help after myocardial infarction
End points in chronic heart failure clinical trials
© Copyright Dialogues in Cardiovascular Medicine